Medical drug program updates

You can refer to the chart below to review changes and updates related to CarePartners of Connecticut's prior authorization and coverage program for medical drugs.

Medications being added to prior authorization

Drug(s)  

Effective date

Policy & additional information

 

 

 

Updates to existing prior authorization programs 

Breyanzi

9/1/2024 

Breyanzi

  • Removed requirement that follicular lymphoma be Grade 3B.

  • Added criteria to include the treatment of adult patients with relapsed or refractory mantle cell lymphoma as third-line therapy, including prior treatment with a Bruton tyrosine kinase inhibitor.